Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

1.

Impact of risk factors on different interval cancer subtypes in a population-based breast cancer screening programme.

Blanch J, Sala M, Ibáñez J, Domingo L, Fernandez B, Otegi A, Barata T, Zubizarreta R, Ferrer J, Castells X, Rué M, Salas D; INCA Study Group.

PLoS One. 2014 Oct 21;9(10):e110207. doi: 10.1371/journal.pone.0110207. eCollection 2014.

PMID:
25333936
[PubMed - in process]
Free PMC Article
2.

Participation and detection rates by age and sex for colonoscopy versus fecal immunochemical testing in colorectal cancer screening.

Salas D, Vanaclocha M, Ibáñez J, Molina-Barceló A, Hernández V, Cubiella J, Zubizarreta R, Andreu M, Hernández C, Pérez-Riquelme F, Cruzado J, Carballo F, Bujanda L, Sarasqueta C, Portillo I, de la Vega-Prieto M, Morillas JD, Valentín V, Lanas A, Quintero E, Castells A.

Cancer Causes Control. 2014 Aug;25(8):985-97. doi: 10.1007/s10552-014-0398-y. Epub 2014 May 24.

PMID:
24859111
[PubMed - in process]
3.

Rate of detection of advanced neoplasms in proximal colon by simulated sigmoidoscopy vs fecal immunochemical tests.

Castells A, Quintero E, Álvarez C, Bujanda L, Cubiella J, Salas D, Lanas A, Carballo F, Morillas JD, Hernández C, Jover R, Hijona E, Portillo I, Enríquez-Navascués JM, Hernández V, Martínez-Turnes A, Menéndez-Villalva C, González-Mao C, Sala T, Ponce M, Andrés M, Teruel G, Peris A, Sopeña F, González-Rubio F, Seoane-Urgorri A, Grau J, Serradesanferm A, Pozo À, Pellisé M, Balaguer F, Ono A, Cruzado J, Pérez-Riquelme F, Alonso-Abreu I, Carrillo-Palau M, de la Vega-Prieto M, Iglesias R, Amador J, Blanco JM, Sastre R, Ferrándiz J, González-Hernández MJ, Andreu M, Bessa X; COLONPREV Study Investigators.

Clin Gastroenterol Hepatol. 2014 Oct;12(10):1708-16.e4. doi: 10.1016/j.cgh.2014.03.022. Epub 2014 Mar 27.

PMID:
24681078
[PubMed - in process]
4.

Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer.

Vilaprinyo E, Forné C, Carles M, Sala M, Pla R, Castells X, Domingo L, Rue M; Interval Cancer (INCA) Study Group.

PLoS One. 2014 Feb 3;9(2):e86858. doi: 10.1371/journal.pone.0086858. eCollection 2014.

PMID:
24498285
[PubMed - in process]
Free PMC Article
5.

Effect of oral anticoagulants on the outcome of faecal immunochemical test.

Bujanda L, Sarasqueta C, Lanas Á, Quintero E, Cubiella J, Hernandez V, Morillas JD, Perez-Fernández T, Salas D, Andreu M, Carballo F, Bessa X, Portillo I, Jover R, Balaguer F, Cosme A, Castells A; COLONPREV study investigators.

Br J Cancer. 2014 Mar 4;110(5):1334-7. doi: 10.1038/bjc.2014.38. Epub 2014 Feb 4.

PMID:
24496455
[PubMed - indexed for MEDLINE]
6.

Tumor phenotype and breast density in distinct categories of interval cancer: results of population-based mammography screening in Spain.

Domingo L, Salas D, Zubizarreta R, Baré M, Sarriugarte G, Barata T, Ibáñez J, Blanch J, Puig-Vives M, Fernández A, Castells X, Sala M; INCA Study Group.

Breast Cancer Res. 2014 Jan 10;16(1):R3. doi: 10.1186/bcr3595.

PMID:
24410848
[PubMed - in process]
Free PMC Article
7.

Trends in detection of invasive cancer and ductal carcinoma in situ at biennial screening mammography in Spain: a retrospective cohort study.

Román M, Rué M, Sala M, Ascunce N, Baré M, Baroja A, De la Vega M, Galcerán J, Natal C, Salas D, Sánchez-Jacob M, Zubizarreta R, Castells X; Cumulative False Positive Risk Group.

PLoS One. 2013 Dec 23;8(12):e83121. doi: 10.1371/journal.pone.0083121. eCollection 2013.

PMID:
24376649
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Risk of advanced proximal neoplasms according to distal colorectal findings: comparison of sigmoidoscopy-based strategies.

Castells A, Bessa X, Quintero E, Bujanda L, Cubiella J, Salas D, Lanas A, Carballo F, Morillas JD, Hernández C, Jover R, Montalvo I, Arenas J, Cosme A, Hernández V, Iglesias B, Castro I, Cid L, Sala T, Ponce M, Andrés M, Teruel G, Peris A, Roncales MP, González-Rubio F, Seoane-Urgorri A, Grau J, Serradesanferm A, Pellisé M, Ono A, Cruzado J, Pérez-Riquelme F, Alonso-Abreu I, Carrillo-Palau M, de la Vega-Prieto M, Iglesias R, Amador J, Blanco JM, Sastre R, Ferrándiz J, González-Hernández MJ, Andreu M; COLONPREV study investigators.

J Natl Cancer Inst. 2013 Jun 19;105(12):878-86. doi: 10.1093/jnci/djt117. Epub 2013 May 24.

PMID:
23708054
[PubMed - indexed for MEDLINE]
Free Article
9.

Cumulative risk of cancer detection in breast cancer screening by protocol strategy.

Blanch J, Sala M, Román M, Ederra M, Salas D, Zubizarreta R, Sanchez M, Rué M, Castells X; CFPR group.

Breast Cancer Res Treat. 2013 Apr;138(3):869-77. doi: 10.1007/s10549-013-2458-5. Epub 2013 Mar 8.

PMID:
23471648
[PubMed - indexed for MEDLINE]
10.

Modifiable endoscopic factors that influence the adenoma detection rate in colorectal cancer screening colonoscopies.

Jover R, Zapater P, Polanía E, Bujanda L, Lanas A, Hermo JA, Cubiella J, Ono A, González-Méndez Y, Peris A, Pellisé M, Seoane A, Herreros-de-Tejada A, Ponce M, Marín-Gabriel JC, Chaparro M, Cacho G, Fernández-Díez S, Arenas J, Sopeña F, de-Castro L, Vega-Villaamil P, Rodríguez-Soler M, Carballo F, Salas D, Morillas JD, Andreu M, Quintero E, Castells A; COLONPREV study investigators.

Gastrointest Endosc. 2013 Mar;77(3):381-389.e1. doi: 10.1016/j.gie.2012.09.027. Epub 2012 Dec 4.

PMID:
23218945
[PubMed - indexed for MEDLINE]
11.

Breast cancer detection risk in screening mammography after a false-positive result.

Castells X, Román M, Romero A, Blanch J, Zubizarreta R, Ascunce N, Salas D, Burón A, Sala M; Cumulative False Positive Risk Group.

Cancer Epidemiol. 2013 Feb;37(1):85-90. doi: 10.1016/j.canep.2012.10.004. Epub 2012 Nov 9.

PMID:
23142338
[PubMed - indexed for MEDLINE]
Free Article
12.

[Breast cancer screening: characteristics and results of the Spanish programs].

Ascunce N, Delfrade J, Salas D, Zubizarreta R, Ederra M; en nombre de Red de Programas de Cribado de Cáncer.

Med Clin (Barc). 2013 Jul 7;141(1):13-23. doi: 10.1016/j.medcli.2012.03.030. Epub 2012 Jun 15. Spanish.

PMID:
22704275
[PubMed - indexed for MEDLINE]
13.

[Current status of research in breast cancer screening in Spain: implications for prevention].

Sala M, Salas D, Zubizarreta R, Ascunce N, Rué M, Castells X; en nombre de los grupos de investigación RAFP e INCA.

Gac Sanit. 2012 Nov-Dec;26(6):574-81. doi: 10.1016/j.gaceta.2011.11.013. Epub 2012 Mar 15. Spanish.

PMID:
22424970
[PubMed - indexed for MEDLINE]
Free Article
14.

Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening.

Quintero E, Castells A, Bujanda L, Cubiella J, Salas D, Lanas Á, Andreu M, Carballo F, Morillas JD, Hernández C, Jover R, Montalvo I, Arenas J, Laredo E, Hernández V, Iglesias F, Cid E, Zubizarreta R, Sala T, Ponce M, Andrés M, Teruel G, Peris A, Roncales MP, Polo-Tomás M, Bessa X, Ferrer-Armengou O, Grau J, Serradesanferm A, Ono A, Cruzado J, Pérez-Riquelme F, Alonso-Abreu I, de la Vega-Prieto M, Reyes-Melian JM, Cacho G, Díaz-Tasende J, Herreros-de-Tejada A, Poves C, Santander C, González-Navarro A; COLONPREV Study Investigators.

N Engl J Med. 2012 Feb 23;366(8):697-706. doi: 10.1056/NEJMoa1108895.

PMID:
22356323
[PubMed - indexed for MEDLINE]
Free Article
15.

Impact of intermediate mammography assessment on the likelihood of false-positive results in breast cancer screening programmes.

Ascunce N, Ederra M, Delfrade J, Baroja A, Erdozain N, Zubizarreta R, Salas D, Castells X; Cumulative False Positive Risk (CFPR) Group.

Eur Radiol. 2012 Feb;22(2):331-40. doi: 10.1007/s00330-011-2263-7. Epub 2011 Sep 8.

PMID:
21901564
[PubMed - indexed for MEDLINE]
16.

Effect of radiologist experience on the risk of false-positive results in breast cancer screening programs.

Alberdi RZ, Llanes AB, Ortega RA, Expósito RR, Collado JM, Verdes TQ, Ramos CN, Sanz ME, Trejo DS, Oliveres XC; CFPR (Cumulative False Positive Risk) group(1).

Eur Radiol. 2011 Oct;21(10):2083-90. doi: 10.1007/s00330-011-2160-0. Epub 2011 Jun 4.

PMID:
21643887
[PubMed - indexed for MEDLINE]
17.

Effect of false-positives and women's characteristics on long-term adherence to breast cancer screening.

Román R, Sala M, De La Vega M, Natal C, Galceran J, González-Román I, Baroja A, Zubizarreta R, Ascunce N, Salas D, Castells X.

Breast Cancer Res Treat. 2011 Nov;130(2):543-52. doi: 10.1007/s10549-011-1581-4. Epub 2011 May 27.

PMID:
21617920
[PubMed - indexed for MEDLINE]
18.

Effect of start age of breast cancer screening mammography on the risk of false-positive results.

Salas D, Ibáñez J, Román R, Cuevas D, Sala M, Ascunce N, Zubizarreta R, Castells X; CFPR (Cumulative False Positive Risk) group.

Prev Med. 2011 Jul-Aug;53(1-2):76-81. doi: 10.1016/j.ypmed.2011.04.013. Epub 2011 May 4.

PMID:
21575653
[PubMed - indexed for MEDLINE]
19.

Effect of false-positive results on reattendance at breast cancer screening programmes in Spain.

Alamo-Junquera D, Murta-Nascimento C, Macià F, Baré M, Galcerán J, Ascunce N, Zubizarreta R, Salas D, Román R, Castells X, Sala M; Cumulative False-Positive Risk Group.

Eur J Public Health. 2012 Jun;22(3):404-8. doi: 10.1093/eurpub/ckr057. Epub 2011 May 9.

PMID:
21558152
[PubMed - indexed for MEDLINE]
Free Article
20.

Effect of protocol-related variables and women's characteristics on the cumulative false-positive risk in breast cancer screening.

Román R, Sala M, Salas D, Ascunce N, Zubizarreta R, Castells X; Cumulative False Positive Risk Group.

Ann Oncol. 2012 Jan;23(1):104-11. doi: 10.1093/annonc/mdr032. Epub 2011 Mar 23.

PMID:
21430183
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk